Camphor oil (Solution) Instructions for Use
Marketing Authorization Holder
Tver Pharmaceutical Factory, PJSC (Russia)
ATC Code
M02AX10 (Other drugs)
Active Substance
Camphor (Ph.Eur. European Pharmacopoeia)
Dosage Form
| Camphor oil | Oil solution for external use 10%: fl. 30 ml, 50 ml, or 100 ml |
Dosage Form, Packaging, and Composition
Oil solution for external use in the form of a transparent oily liquid of yellow color with a camphor odor.
| 100 ml | |
| Camphor (Synthetic Camphor) | 10 g |
Excipients: sunflower oil – up to 100 ml.
30 ml – orange glass bottles (1) – cardboard packs.
50 ml – orange glass bottles (1) – cardboard packs.
100 ml – orange glass bottles (1) – cardboard packs.
Clinical-Pharmacological Group
Analgesic and local anesthetic agent for external use
Pharmacotherapeutic Group
Local irritant of natural origin
Pharmacological Action
A preparation for external use. It has antiseptic, local irritant, local analgesic, and anti-inflammatory effects.
By stimulating the sensitive nerve endings of the skin, it dilates blood vessels and improves the trophism of organs and tissues.
Pharmacokinetics
When applied to the skin surface, it is partially absorbed and undergoes oxidation.
The oxidation products bind with glucuronic acid and are excreted by the kidneys.
A portion of the camphor is excreted unchanged through the respiratory tract and with bile.
Indications
- Arthralgia;
- Myalgia;
- Sciatica;
- Myositis;
- Radiculitis;
- Prevention of pressure sore development.
ICD codes
| ICD-10 code | Indication |
| M25.5 | Pain in joint |
| M54.1 | Radiculopathy |
| M54.3 | Sciatica |
| M54.5 | Low back pain |
| M54.9 | Dorsalgia, unspecified |
| M79.1 | Myalgia |
| Z51.4 | Preparatory procedures for subsequent treatment or examination, not elsewhere classified |
| ICD-11 code | Indication |
| 8B93.Z | Radiculopathy, unspecified |
| 8E4A.1 | Paraneoplastic or autoimmune diseases of the peripheral or autonomic nervous system |
| FB56.2 | Myalgia |
| ME82 | Pain in joint |
| ME84.2Z | Low back pain, unspecified |
| ME84.3 | Sciatica |
| ME84.Z | Back pain, unspecified |
| QB9A | Preparatory procedures for subsequent treatment |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Apply the preparation externally only.
Apply a small amount to the skin in the area of pain.
Rub it in with light movements until fully absorbed.
Repeat this procedure 2-3 times per day.
The standard treatment duration is 7-10 days.
Do not exceed the recommended frequency or duration of application.
For prevention of pressure sores, treat the at-risk skin areas 2-3 times per day.
Avoid application to broken skin, mucous membranes, or near the eyes.
Discontinue use and consult a physician if severe skin irritation or allergic reactions occur.
Adverse Reactions
Possible allergic skin reactions (urticaria), skin irritation, headache, dizziness.
Contraindications
- Hypersensitivity to the components of this preparation;
- Predisposition to convulsive reactions;
- Impaired integrity of the skin;
- Inflammatory skin diseases at the site of intended application (including dermatitis, eczema);
- Pregnancy;
- Breastfeeding period;
- Children and adolescents under 18 years of age.
Use in Pregnancy and Lactation
Use is contraindicated during pregnancy and breastfeeding.
Pediatric Use
The drug is contraindicated for use in children and adolescents under 18 years of age.
Geriatric Use
The drug is contraindicated for use in elderly patients.
Special Precautions
Avoid getting the preparation on open wounds, in the eyes, and on mucous membranes.
In case of overdose, agitation, tachycardia, and convulsions are observed. Symptomatic therapy is performed.
Effect on the ability to drive vehicles and machinery
During the treatment period, caution should be exercised when engaging in potentially hazardous activities that require increased concentration and speed of psychomotor reactions (including driving vehicles, working with moving machinery).
Storage Conditions
Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Over-the-Counter
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer